Cargando…
Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) targeted prostate biopsy increases the diagnostic accuracy of clinically significant prostate cancer (PCa). Currently there is no consensus on which type of MRI-targeted biopsy performs better in a given setting. In this study, we aimed...
Autores principales: | Zhang, Kai, Zhang, Zhipeng, Liu, Ming, Zhu, Gang, Roobol, Monique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214969/ https://www.ncbi.nlm.nih.gov/pubmed/32420129 http://dx.doi.org/10.21037/tau.2020.02.20 |
Ejemplares similares
-
In-bore MRI targeted biopsy
por: Gurgitano, Martina, et al.
Publicado: (2020) -
Imaging of clinically silent rectoprostatic hematoma in MRI guided in-bore prostate biopsy
por: Garmer, Marietta, et al.
Publicado: (2022) -
Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study
por: Pizzoli, Silvia Francesca Maria, et al.
Publicado: (2020) -
Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer
por: Venderink, Wulphert, et al.
Publicado: (2017) -
Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)